Demystifying Itron: Insights From 6 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Itron (NASDAQ:ITRI) has been evaluated by 6 analysts over the last three months, showing a diverse range of opinions. Recent assessments indicate a shift towards a more bullish outlook, with the average 12-month price target for Itron now at $83.00, up 18.57% from the previous $70.00. Analyst actions include rating changes and price target adjustments, reflecting an optimistic view on Itron's financial performance, which has shown significant revenue growth, a high net margin, and strong ROE and ROA, outperforming industry averages.
February 27, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Itron has received increasingly positive evaluations from analysts, with a significant upward revision in the 12-month price target to $83.00. The company's financial performance, including a 33.24% revenue growth and high profitability metrics, supports this optimistic outlook.
The positive shift in analyst sentiment, evidenced by the raised price targets and bullish ratings, is likely to influence investor perception positively in the short term. Itron's impressive financial performance, particularly in revenue growth and profitability, further substantiates the analysts' optimistic outlook, suggesting a potential upward movement in ITRI's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100